MeSH D006945 - hyperhidrosis
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
Events Timeline
Commercial
Company Name | Drug Name | Trade Name | Patent Expires | Approval Date | Revenue | Period |
|---|---|---|---|---|---|---|
| AbbVie | Onabotulinumtoxina | Botox |  | 1991-12-09 |  |  |
| AstraZeneca | Glycopyrronium, Formoterol | Bevespi Aerosphere |  | 2018-12-18 |  |  |
| Budesonide, Glycopyrronium, Formoterol | Riltrava Aerosphere |  | 2022-01-06 |  |  | |
| Budesonide, Glycopyrronium, Formoterol | Trixeo Aerosphere |  | 2020-12-09 |  |  | |
| Chiesi Farmaceutici | Glycopyrronium, Beclometasone, Formoterol | Trimbow |  | 2017-07-17 |  |  |
| Glycopyrronium, Beclometasone, Formoterol | Trydonis |  | 2018-04-26 |  |  | |
| Ipsen | Abobotulinumtoxina | Dysport |  | 2009-04-29 |  |  |
| Journey Medical | Glycopyrronium | Qbrexza | 2028-10-17 | 2018-06-28 |  |  |
| Novartis | Indacaterol, Glycopyrronium, Mometasone | Enerzair Breezhaler |  | 2020-07-03 |  |  |
| Glycopyrronium | Enurev Breezhaler |  | 2012-09-28 |  |  | |
| Glycopyrronium | Seebri Breezhaler |  | 2012-09-28 |  |  | |
| Glycopyrronium | Tovanor Breezhaler |  | 2012-09-28 |  |  | |
| Indacaterol, Glycopyrronium | Ultibro Breezhaler |  | 2013-09-19 |  |  | |
| Indacaterol, Glycopyrronium | Ulunar Breezhaler |  | 2014-04-23 |  |  | |
| Indacaterol, Glycopyrronium | Xoterna Breezhaler |  | 2013-09-18 |  |  | |
| Indacaterol, Glycopyrronium, Mometasone furoate | Zimbus Breezhaler |  | 2020-07-03 |  |  | |
| Proveca | Glycopyrronium | Sialanar |  | 2016-09-15 |  |  |
Clinical Trials
Historical Success Rate
Phase 1
100%5/5
Phase 2
44%4/9
Phase 3
100%6/6
Approved: 2Overall Success rate: 44%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name | Phase 1 | Phase 2 | Phase 3 | Phase 4 | Drug Name |
|---|---|---|---|---|---|
© 2020-2023 Collaborative Drug Discovery Inc. (CDD) | Terms of Use